New Colon Cancer Prognostic Biomarker: A ‘Potentially Import
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The recent identification of a prognostic biomarker for earlier-stage colon cancer by an international research group is a provocative finding that, if further validated, could help guide treatment decisions and suggest new therapeutic targets, says Cleveland Clinic Cancer Center colorectal surgeon and scientist Emina Huang, MD.

The discovery that the expression status of transcription factor caudal-type homeobox transcription factor 2 (CDX2) is indicative of disease-free survival and response to adjuvant chemotherapy in a subset of stage II colon cancer patients is “biologically intriguing and a potentially quite important clinical advance,” says Dr. Huang, a colorectal surgeon and researcher in the Department of Stem Cell Biology and Regenerative Medicine...

https://consultqd.clevelandclinic.org/2016/05/new-colon-cancer-prognostic-biomarker-potentially-important-clinical-advance/
Preview
Like
Comment
Share